MAPK1 and colorectal carcinoma: In cancer, EPI/NE in the TME predominantly activate pathways such as ERK/MAPK and cAMP/PKA via β2‐AR and other receptors, promoting tumor proliferation and metastasis (e.g., GC and CRC) while inhibiting only certain tumors, such as melanoma.